Back

Genetic variability of lipoprotein(a) controls vascular inflammation/redox signalling and predicts adverse cardiovascular outcomes in coronary artery disease

28 August 2023 (09:15 - 09:50)
Organised by: Logo
Congress Presentation Part of: Metabolic markers in chronic coronary syndrome Inflammation and Immunity ESC Professional Premium Access ESC Congress 2023 European Society of Cardiology

About the speaker

Photo
Doctor Murray David Polkinghorne

University of Oxford, Oxford (United Kingdom of Great Britain & Northern Ireland)

5 More presentations in this session

Presentation thumbnail
Gamma-Glutamyl Transferase as a prognostic risk factor in complex coronary disease: a serendipitous (re)discovery of machine learning in the SYNTAXES?
Doctor K. Ninomiya (Morioka, JP)
Abstract Slides Video
Presentation thumbnail
Relationship between stress hyperglycemia ratio and long-term poor prognosis in patients with multi-vessel coronary artery disease
Doctor M. Li (Nanjing, CN)
Abstract Slides Video
Presentation thumbnail
Iron deficiency and association with mortality in patients with coronary artery disease
Doctor N. Corballis (Norwich, GB)
Abstract Slides Video
Presentation thumbnail
Impact of transfusion on platelet aggregation and biomarkers in myocardial infarction patients with anemia: an ancillary study of the randomized REALITY trial
Professor B. Lattuca (Nimes, FR)
Abstract Slides Video
Presentation thumbnail
Association between index of microcirculatory resistance and patients' characteristics, coronary computed tomography findings, and the sensor location
Doctor M. Hada (Aalst, BE)
Abstract Slides Video

Access the full session

Session thumbnail
Metabolic markers in chronic coronary syndrome

The Event

Event poster

ESC Congress 2023

28 August 2023 09:15 CET
You may be interested in
thumbnail
Congress Presentation
Lipoprotein(a) regulates vascular redox state and inflammatory response in patients with coronary artery disease
thumbnail
Congress Presentation
Does the LPA genotype have a role in coronary artery disease risk beyond Lp(a) values?
thumbnail
Congress Presentation
The impact of very highly elevated lipoprotein(a) levels on the early onset, complexity, and extent of coronary artery disease

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources